What Is the Risk of Developing GCA if You Have PMR?
At a Glance
If you have Polymyalgia Rheumatica (PMR), you have a 15% to 20% risk of developing Giant Cell Arteritis (GCA). The low steroid doses used to treat PMR do not prevent GCA, so it is critical to watch for warning signs like new headaches, jaw pain when chewing, and sudden vision changes.
In this answer
3 sections
If you have Polymyalgia Rheumatica (PMR), your risk of eventually developing Giant Cell Arteritis (GCA) is generally between 15% and 20% [1][2]. PMR and GCA are not completely separate diseases; they are closely related conditions that exist on the same disease spectrum [3][4]. While PMR causes inflammation primarily in the joints and muscles (leading to stiffness), GCA involves inflammation of the blood vessels.
Because of this strong connection, anyone diagnosed with PMR needs to remain vigilant for the signs of GCA. Fortunately, if GCA is caught early, it is highly treatable and irreversible damage can be prevented.
The Steroid Misconception
A common and dangerous misconception is that because you are already taking steroids (such as prednisone) for PMR, you are protected against getting GCA. This is not true.
The standard steroid doses used to treat PMR—typically between 12.5 and 20 mg per day—are not high enough to prevent the blood vessel inflammation of GCA [5][6]. GCA usually requires much higher starting doses, often between 40 and 60 mg daily, to stop the inflammation and protect your vision.
Furthermore, the lower doses of steroids used for PMR can sometimes hide or “mask” the early warning signs of GCA [5][7]. GCA can develop at any time during your PMR journey, but it is especially important to be on guard when you and your doctor are tapering (gradually lowering) your steroid dose [5][7].
Red Flag Symptoms to Watch For
Because GCA can develop suddenly and threatens your vision, you must know the warning signs. If you experience any of the following symptoms, do not wait for your next scheduled appointment.
- Vision Changes (Medical Emergency): Any sudden blurring, double vision, shadows, or temporary loss of vision in one or both eyes requires an immediate trip to the Emergency Room [8][9]. Do not wait for a doctor’s callback, as urgent treatment is required to prevent permanent blindness.
- New or Unusual Headaches: This is often the most common symptom. It is usually a new type of headache that you haven’t experienced before, frequently located in the temples, though it can occur anywhere on the head [10][11].
- Jaw Claudication (Jaw Pain): This is pain, cramping, or fatigue in your jaw muscles that happens when you are chewing food or talking for a long time [12][13]. This happens because the chewing muscles aren’t getting enough blood flow, which helps distinguish it from standard joint pain or TMJ issues.
- Scalp Tenderness: You may notice pain when brushing your hair, washing your scalp, or wearing glasses or a hat [10].
- Return of Flu-Like Symptoms: If you experience unexplained fever, extreme fatigue, or a sudden return of severe stiffness while taking steroids, it may be a sign of spreading inflammation [6][7]. While normal PMR flares can happen during a steroid taper (usually as returning joint stiffness), a flare accompanied by fever, head pain, or the symptoms above strongly points toward GCA.
“Silent” Inflammation
Recent research has shown that some patients with newly diagnosed PMR actually have “subclinical” GCA—meaning they have blood vessel inflammation that is not yet causing obvious symptoms [1][2]. Because of this, your doctor may regularly monitor your blood tests for inflammatory markers, specifically C-Reactive Protein (CRP) and Erythrocyte Sedimentation Rate (ESR), even when you feel well [6]. They may also suggest imaging tests like an ultrasound, which typically checks the temporal arteries (at the temples) or axillary arteries (in the armpits), to look at your blood vessels directly [7].
Common questions in this guide
Does taking steroids for PMR prevent me from getting GCA?
What does jaw claudication feel like?
Why does my doctor check my CRP and ESR levels if I feel fine?
What should I do if my vision suddenly changes while I have PMR?
Is it normal for symptoms to return when I lower my steroid dose?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Given my PMR diagnosis, how frequently should we be checking my inflammatory markers (CRP and ESR) to watch for GCA?
- 2.What is your specific protocol if I experience a new headache or jaw pain outside of office hours?
- 3.Should I undergo a baseline ultrasound to check my temporal or axillary arteries for silent inflammation?
- 4.If my PMR symptoms flare up while tapering my steroids, how do we determine if it's just a PMR flare or if GCA is developing?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (13)
- 1
Prevalence and characteristics of giant cell arteritis in patients with newly diagnosed polymyalgia rheumatica - a prospective cohort study.
Burg LC, Karakostas P, Behning C, et al.
Therapeutic advances in musculoskeletal disease 2023; (15()):1759720X221149963 doi:10.1177/1759720X221149963.
PMID: 36777696 - 2
Low incidence of late-onset giant cell arteritis during the first year in patients with polymyalgia rheumatica-a repeated imaging study.
Nielsen AW, Hauge EM, Hansen IT, et al.
Rheumatology (Oxford, England) 2025; (64(4)):2193-2198 doi:10.1093/rheumatology/keae463.
PMID: 39180419 - 3
Musculoskeletal magnetic resonance imaging findings support a common spectrum of giant cell arteritis and polymyalgia rheumatica.
Seitz P, Cullmann J, Bucher S, et al.
Rheumatology (Oxford, England) 2025; (64(1)):321-331 doi:10.1093/rheumatology/keae043.
PMID: 38265241 - 4
Risk of venous and arterial thromboembolism in patients with giant cell arteritis and/or polymyalgia rheumatica: A Veterans Health Administration population-based study in the United States.
Michailidou D, Zhang T, Stamatis P, Ng B
Journal of internal medicine 2022; (291(5)):665-675 doi:10.1111/joim.13446.
PMID: 34982490 - 5
Giant cell arteritis with spontaneous remission.
Álvarez-Lario B, Lorenzo-Martín JA, Colazo-Burlato M, et al.
Modern rheumatology case reports 2022; (6(1)):75-79 doi:10.1093/mrcr/rxab001.
PMID: 34491342 - 6
Predictive Factors of Giant Cell Arteritis in Polymyalgia Rheumatica Patients.
Ramon A, Greigert H, Ornetti P, et al.
Journal of clinical medicine 2022; (11(24)) doi:10.3390/jcm11247412.
PMID: 36556036 - 7
A Case of Giant Cell Arteritis Presenting With a Hyperechoic Wall Thickening on Temporal Artery Ultrasonography.
Yoshida K, Jinnouchi S, Fukuchi T
Cureus 2025; (17(10)):e95118 doi:10.7759/cureus.95118.
PMID: 41287655 - 8
Every minute blinds: Temporal artery ultrasound in the real-time diagnosis of stroke of the eye.
Avasarala J, Gangadhara S, Bobadilla J, Chadha R
The American journal of emergency medicine 2026; (99()):97-101 doi:10.1016/j.ajem.2025.09.027.
PMID: 41004929 - 9
[Delays in the management of ocular complications of giant cell arteritis: A retrospective monocentric study of 33 patients].
Sené T, Clavel G, Villeneuve D, et al.
La Revue de medecine interne 2020; (41(10)):661-666 doi:10.1016/j.revmed.2020.06.012.
PMID: 32682624 - 10
Apical Orbital Aspergillosis Complicating Giant Cell Arteritis.
Zhou Y, Morgan ML, Almarzouqi SJ, et al.
Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society 2016; (36(2)):159-63 doi:10.1097/WNO.0000000000000344.
PMID: 26835662 - 11
Baseline clinical predictors of an ultimate giant cell arteritis diagnosis in patients referred to temporal artery biopsy.
Grossman C, Barshack I, Koren-Morag N, et al.
Clinical rheumatology 2016; (35(7)):1817-22 doi:10.1007/s10067-016-3221-1.
PMID: 26925851 - 12
Predictive Factors for Biopsy-Negative Giant Cell Arteritis and Alternative Diagnoses in a Neuro-Ophthalmology Context.
Kwok L, Wu E, Sheth SJ, et al.
Neuro-ophthalmology (Aeolus Press) 2024; (48(4)):267-271 doi:10.1080/01658107.2024.2311131.
PMID: 38933754 - 13
Temporal headache and jaw claudication may be the key for the diagnosis of giant cell arteritis.
Peral-Cagigal B, Pérez-Villar Á, Redondo-González LM, et al.
Medicina oral, patologia oral y cirugia bucal 2018; (23(3)):e290-e294 doi:10.4317/medoral.22298.
PMID: 29680850
This page provides general information about the risk of developing GCA when you have PMR for educational purposes. It does not replace professional medical advice, and you should seek immediate emergency care for any sudden vision changes.
Get notified when new evidence is published on Giant cell arteritis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.